Taro appoints new Chief Financial Officer

Mr. Balaguer has nearly 20 years of senior management experience in finance with global companies

joint-venture

Taro Pharmaceutical Industries Ltd. announced the appointment of Mariano Balaguer as Vice President, CFO and Chief Accounting Officer.

Mr. Balaguer has nearly 20 years of senior management experience in finance with global companies such as Novartis Consumer Health, Nestle and most recently, the Global Strategic Portfolio Division of Henry Schein.

With Henry Schein, Mr. Balaguer was responsible for the finance functions of the business working to expand the investment and profitability of the group as well as further the capabilities of the financial teams. He worked closely with the financial leaders of Henry Schein's affiliate companies in all aspects of financial reporting, planning, expense control, tax, treasury, M&A and other financial matters.

Regarding the appointment, Mr. Sundaram, Taro's CEO, commented, "We are very pleased to have Mariano join the Taro team. His extensive financial background in related industries and his international experience will help strengthen our management team and contribute to the continuing growth and expansion of our business."

Mr. Balaguer earned a Bachelor's Degree in Economics from the Universidad Nacional de Cuyo, Argentina and an MBA from New York University Stern School of Business.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X